期刊文献+

右美托咪定对肺癌根治术患者单肺通气时的肺保护作用 被引量:42

Pulmonary protection of dexmedetomidine during one-lung ventilation in patients undergoing radical operation for lung cancer
原文传递
导出
摘要 目的评价右美托咪定对肺癌根治术患者单肺通气时的肺保护作用。方法择期拟行肺癌根治术患者30例,性别不限,年龄40-70岁,体重50~80kg,ASA分级I.Ⅲ级。采用随机数字表法,将其分为2组(n:15):右美托咪定组(D组)和对照组(C组)。D组于麻醉诱导前经10min静脉输注右美托咪定负荷量1.0μg/kg,随后以0.6μg·kg^-1·h^-1速率静脉输注至关胸。C组给予等容量生理盐水。于麻醉诱导后即刻(Tl)、单肺通气30min(T2)、60min(T3)、术毕(T4)时分别采集动脉血,采用ELISA法测定血清TNF-a、IL-6及IL-8的浓度,并行动脉血气分析,计算氧合指数。结果与C组比较,D组血清TNF叱IL-6和IL-8浓度降低,氧合指数升高(P〈0.05)。结论右美托咪定可减轻肺癌根治术患者单肺通气期间肺组织炎性反应,改善肺功能,产生肺保护作用。 Objective To evaluate the pulmonary protection of dexmedetomidine during one-lung ventilation in patients undergoing radical operation for lung cancer. Methods Thirty patients of both sexes, aged 40-70 yr, weighing 50-80 kg, of ASA physical status Ⅰ-Ⅲ , scheduled for elective radical operation for lung cancer, were randomized into 2 groups ( n = 15 each) : dexmedetomidine group ( group D) and control group (group C ). Before induction of anesthesia, a loading dose of dexmedetomidine 1.0 μg/kg was infused over 10 min, followed by continuous infusion of dexmedetomidine at a rate of 0.6μg· kg^- 1· h- 1 until the chest was closed in group D, while the equal volume of normal saline was given in group C. Immediately after induction of anesthesia, at 30 and 60 min of one-lung ventilation, and at the end of operation, arterial blood samples were collected for determination of the serum concentrations of TNF-a, IL-6 and IL-8, and for blood gas analysis. Oxygenation index was calculated. Results Compared with group C, the serum concentrations of TNF-a, IL-6 and IL-8 were significantly decreased, and oxygenation index was increased in group D. Conclusion Dexmedetomidine can mitigate inflammatory responses during one-lung ventilation and improve pulmonary function, thus providing pulmonary protection in patients undergoing radical operation for lung cancer.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2014年第6期674-676,共3页 Chinese Journal of Anesthesiology
关键词 右美托咪啶 呼吸 人工 全身炎症反应综合征 呼吸功能试验 Dexmedetomidine Respiration, artificial Systemic inflammatory response syndrome Respiratory function tests
  • 相关文献

参考文献9

二级参考文献56

  • 1刘东,曾邦雄,张诗海,耿智隆,张世范.PPARγ受体激动剂抑制急性肺损伤大鼠肺脏粘附分子和趋化因子的表达[J].中国病理生理杂志,2006,22(8):1558-1561. 被引量:5
  • 2杨静,李立环.围术期心肌缺血的监测和治疗[J].临床麻醉学杂志,2006,22(9):719-721. 被引量:15
  • 3Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomi- dine: a review of clinical applications. Curt Opin Anaesthesiol, 2008,21:457-461. 被引量:1
  • 4Worster A, Devereaux PJ, Heels-Ansdell D, et al. Capability of ischemia modified albumin to predict serious cardiac outcomes in the shortterm among patients with potential acute coronary syndrome. Can Med Assoc J,2005,172:1685-1690. 被引量:1
  • 5Apple FS,Wu AH, Mair J, et al. Future biomarkers for detec- tion of ishhemia and risk tratification in acute coronary syn- drome. Clin Chem, 2005,51 : 810-824. 被引量:1
  • 6Quiles J,Roy D,Gaze D,et al. Relation of ischemia modified al- bumin levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol, 2003,92:322-324. 被引量:1
  • 7Kanda H, Kunisawa T, Kurosawa A, et al. Effect of dexme- detomidine on anesthetic requirements in cardiovascular sur- gery. Masui, 2009,58 : 1496-1500. 被引量:1
  • 8Lin TF, Yeh YC, Lin FS, et al. Effect of combining dexme- detomidine and morphine for intravenous patient-controlled an- algesia. Br J Anaesth, 2009,102 : 117-122. 被引量:1
  • 9Wijeysundera DN, Nail JS, Beattie WS. Aplha-2 adrenergic ag- onists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med, 2003,114 : 742. 被引量:1
  • 10Brochard L, Roudot-Thoraval, Roupie E, et al. Tidal volume reduction for revention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS[J]. Am J Respir Crit Care Med, 1998, 被引量:1

共引文献135

同被引文献318

引证文献42

二级引证文献313

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部